Intuitive Surgical Posts Q3 Earnings Beat, These Analysts Raise Forecasts On DV5 Uptake
Portfolio Pulse from Priya Nigam
Intuitive Surgical (NASDAQ:ISRG) reported strong Q3 earnings, surpassing expectations with a 12% earnings beat and 17% revenue growth. Analysts have raised price targets, citing robust procedure volume growth and the successful uptake of the da Vinci 5 system. The company is well-positioned for continued growth, with plans for a broad launch of the DV5 in mid-2025.
October 18, 2024 | 4:19 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Intuitive Surgical reported a strong Q3 earnings beat, with 17% revenue growth and a 12% earnings beat. Analysts have raised price targets, driven by robust procedure volume growth and the successful uptake of the da Vinci 5 system.
The strong Q3 earnings report, with a 12% earnings beat and 17% revenue growth, indicates positive financial performance. Analysts have raised price targets, reflecting confidence in the company's growth prospects, particularly with the successful uptake of the da Vinci 5 system. This is likely to positively impact ISRG's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100